Log in

TSE:LEAFMedReleaf Stock Price, Forecast & News

Add
Compare
Today's Range N/A
50-Day Range
C$24.47
MA: C$24.47
C$24.47
52-Week Range N/A
Volume758,368 shs
Average Volume729,112 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
MedReleaf Corp. produces and sells cannabis-based pharmaceutical products in Canada. It offers dried cannabis, cannabis oils, and cannabis oil capsules; and various accessories, including grinders, vaporizers, and lockable containers. The company was incorporated in 2013 and is headquartered in Markham, Canada.
Read More
MedReleaf logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryCannabis
SectorMedical
CUSIPN/A
CIKN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableOptionable

Receive LEAF News and Ratings via Email

Sign-up to receive the latest news and ratings for LEAF and its competitors with MarketBeat's FREE daily newsletter.

MedReleaf (TSE:LEAF) Frequently Asked Questions

Has MedReleaf been receiving favorable news coverage?

Press coverage about LEAF stock has been trending extremely negative on Saturday, InfoTrie Sentiment reports. The research group rates the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. MedReleaf earned a coverage optimism score of -5.0 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the next several days. View the latest news aboutMedReleaf.

Who are some of MedReleaf's key competitors?

What other stocks do shareholders of MedReleaf own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MedReleaf investors own include Canopy Growth (WEED), Aurora Cannabis (ACB), Aurora Cannabis (ACB), Canopy Growth (CGC), GW Pharmaceuticals PLC- (GWPH), Aurora Cannabis (ACBFF), Cronos Group (CRON), CannTrust (CTST), OrganiGram (OGI) and Energous (WATT).

Who are MedReleaf's key executives?

MedReleaf's management team includes the following people:
  • Mr. Neil J. Closner, CEO, Co-Founder & Director
  • Mr. Igor Gimelshtein, CFO & Corp. Sec.
  • Mr. Donald Courtney, Chief Operating Officer
  • Ms. Christie Hall, VP of Fin. & Accounting
  • Dr. Jeremy N. Friedberg, Chief Science Officer

What is MedReleaf's stock symbol?

MedReleaf trades on the Toronto Stock Exchange (TSX) under the ticker symbol "LEAF."

How do I buy shares of MedReleaf?

Shares of LEAF and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is MedReleaf's official website?

The official website for MedReleaf is medreleaf.com.

This page was last updated on 6/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.